Credit Suisse Ag Kodiak Sciences Inc. Transaction History

Credit Suisse Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$4.81 - $8.88 $43 - $79	9 Added 0.03%	26,030 $161,000
Q4 2022 Feb 13, 2023	SELL	$6.52 - $8.05 $1,727 - $2,133	-265 Reduced 1.01%	26,021 $186,000
Q3 2022 Nov 10, 2022	BUY	$7.57 - $12.5 $1,180 - $1,950	156 Added 0.6%	26,286 $203,000
Q2 2022 Aug 12, 2022	SELL	$5.04 - $9.48 $6,138 - $11,546	-1,218 Reduced 4.45%	26,130 $199,000
Q1 2022 May 16, 2022	BUY	$7.09 - $89.45 $20,667 - $260,746	2,915 Added 11.93%	27,348 $212,000
Q4 2021 Feb 14, 2022	BUY	$80.85 - $128.49 $20,374 - $32,379	252 Added 1.04%	24,433 $2.07 Million
Q3 2021 Nov 12, 2021	SELL	$81.97 - $106.94 $375,668 - $490,106	-4,583 Reduced 15.93%	24,181 $2.32 Million
Q2 2021 Aug 16, 2021	BUY	$77.2 - $126.54 $373,725 - $612,580	4,841 Added 20.24%	28,764 $2.68 Million
Q1 2021 May 14, 2021	SELL	$110.45 - $164.47 $2.56 Million - $3.81 Million	-23,136 Reduced 49.16%	23,923 $2.71 Million
Q4 2020 Feb 12, 2021	SELL	$60.78 - $154.03 $35,799 - $90,723	-589 Reduced 1.24%	47,059 $6.91 Million
Q3 2020 Nov 13, 2020	SELL	$45.05 - $59.27 $157,900 - $207,741	-3,505 Reduced 6.85%	47,648 $2.82 Million
Q2 2020 Aug 12, 2020	BUY	$42.74 - $66.25 $1.31 Million - $2.04 Million	30,748 Added 150.69%	51,153 $2.77 Million
Q1 2020 May 13, 2020	SELL	$38.18 - $73.95 $727,710 - $1.41 Million	-19,060 Reduced 48.3%	20,405 $974,000
Q4 2019 Feb 12, 2020	BUY	$13.9 - $76.65 $548,563 - $3.02 Million	39,465 New	39,465 $2.84 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.